Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 92.80%-205.46M | ---- | -802.91%-2.86B | ---- | -396.41%-316.2M | ---- | -81.68%106.68M | ---- | 80.22%582.37M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 36.31%-677K | ---- | 42.42%-1.06M | ---- | 15.67%-1.85M | ---- | 44.93%-2.19M | ---- | -64.46%-3.98M |
| Attributable subsidiary (profit) loss | ---- | -102.28%-16.13M | ---- | 259.16%705.9M | ---- | 2,190.88%196.54M | ---- | 96.43%-9.4M | ---- | -294.14%-263.57M |
| Impairment and provisions: | ---- | -98.94%13.1M | ---- | 1,422.37%1.24B | ---- | 143.11%81.51M | ---- | 111.68%33.53M | ---- | 313.44%15.84M |
| -Impairment of property, plant and equipment (reversal) | ---- | -170.58%-9.4M | ---- | 35.77%13.31M | ---- | --9.81M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -115.84%-2.49M | ---- | 500.48%15.72M | ---- | -236.33%-3.93M | ---- | -73.68%2.88M | ---- | 273.86%10.94M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | 146.65%75.52M | ---- | 529.09%30.62M | ---- | 203.81%4.87M |
| -Other impairments and provisions | ---- | -97.94%24.98M | ---- | 1,091,657.66%1.21B | ---- | 258.06%111K | ---- | -6.06%31K | ---- | 104.73%33K |
| Revaluation surplus: | ---- | -359.45%-13.25M | ---- | 192.00%5.11M | ---- | 165.81%1.75M | ---- | -55.81%658K | ---- | 887.83%1.49M |
| -Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 125.00%900K |
| -Derivative financial instruments fair value (increase) | ---- | -359.45%-13.25M | ---- | 192.00%5.11M | ---- | 165.81%1.75M | ---- | 11.71%658K | ---- | 200.00%589K |
| Asset sale loss (gain): | ---- | -1,656.75%-94.64M | ---- | 122.35%6.08M | ---- | 155.80%2.73M | ---- | 46.75%-4.9M | ---- | -1,936.73%-9.2M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --7.17M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -8,606.07%-94.64M | ---- | -139.76%-1.09M | ---- | 228.96%2.73M | ---- | -147.91%-2.12M | ---- | 783.23%4.43M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.60%-2.78M | ---- | ---13.63M |
| Depreciation and amortization: | ---- | -41.12%151.47M | ---- | -5.86%257.25M | ---- | -17.03%273.26M | ---- | 0.12%329.35M | ---- | 17.14%328.95M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | -50.00%1.44M | ---- | -0.03%2.88M | ---- | 0.00%2.88M |
| Financial expense | ---- | 8.02%341.54M | ---- | 35.81%316.18M | ---- | 10.66%232.81M | ---- | -4.60%210.39M | ---- | -11.53%220.54M |
| Special items | ---- | -83.59%9.63M | ---- | 2,041.73%58.72M | ---- | -111.37%-3.02M | ---- | 124.14%26.61M | ---- | 1,431.61%11.87M |
| Operating profit before the change of operating capital | ---- | 169.79%185.6M | ---- | -156.88%-265.94M | ---- | -32.31%467.55M | ---- | -21.89%690.72M | ---- | 12.10%884.3M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 176.55%341.52M | ---- | 133.74%123.49M | ---- | 152.12%52.83M | ---- | 74.04%-101.36M | ---- | -376.28%-390.43M |
| Accounts receivable (increase)decrease | ---- | -135.19%-43.79M | ---- | 134.00%124.43M | ---- | 82.50%-365.96M | ---- | -447.97%-2.09B | ---- | 483.91%600.96M |
| Accounts payable increase (decrease) | ---- | -154.05%-58.85M | ---- | 292.84%108.87M | ---- | -104.28%-56.46M | ---- | 2,160.55%1.32B | ---- | -84.08%58.31M |
| prepayments (increase)decrease | ---- | -131.62%-45.92M | ---- | 17.90%145.23M | ---- | -10.00%123.18M | ---- | 440.42%136.86M | ---- | 72.32%-40.2M |
| Special items for working capital changes | ---- | -9,098.98%-115.1M | ---- | -98.93%1.28M | ---- | 115.69%119.67M | ---- | -202.08%-762.57M | ---- | 1,448.00%747.02M |
| Cash from business operations | ---- | 11.00%263.47M | ---- | -30.36%237.36M | ---- | 142.10%340.81M | ---- | -143.52%-809.43M | ---- | 78.36%1.86B |
| Hong Kong profits tax paid | ---- | 77.18%-962K | ---- | 37.45%-4.22M | ---- | -13.03%-6.74M | ---- | -145.06%-5.96M | ---- | 1,993.51%13.23M |
| Other taxs | ---- | -302.23%-10.11M | ---- | 88.07%-2.51M | ---- | 5.57%-21.07M | ---- | 47.79%-22.31M | ---- | -40.13%-42.73M |
| Interest paid - operating | ---- | 19.98%-2.95M | ---- | -5.17%-3.68M | ---- | 11.97%-3.5M | ---- | -51.14%-3.98M | ---- | -152.59%-2.63M |
| Special items of business | -187.54%-86.15M | ---- | -21.91%98.42M | ---- | 513.95%126.03M | ---- | 102.55%20.53M | ---- | -243.48%-804.87M | ---- |
| Net cash from operations | -187.54%-86.15M | 9.92%249.46M | -21.91%98.42M | -26.67%226.95M | 513.95%126.03M | 136.77%309.51M | 102.55%20.53M | -146.05%-841.68M | -243.48%-804.87M | 80.63%1.83B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -36.31%677K | ---- | -42.42%1.06M | ---- | -15.67%1.85M | ---- | -44.93%2.19M | ---- | 23.56%3.98M |
| Restricted cash (increase) decrease | 61.29%-12K | 79.86%-56K | ---31K | 99.01%-278K | ---- | -525.36%-28.17M | ---- | -129.94%-4.5M | ---- | 3,630.75%15.04M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 268.04%48.82M |
| Decrease in deposits (increase) | -181.29%-239K | -94.94%1.09M | -98.41%294K | 63.64%21.43M | -24.87%18.54M | 3,696.98%13.09M | 72.97%24.68M | -101.33%-364K | -47.69%14.27M | 284.78%27.37M |
| Sale of fixed assets | --11K | --2.75M | ---- | ---- | ---- | -91.25%7.84M | -99.54%392K | 957.71%89.69M | -63.74%85.97M | 20,090.48%8.48M |
| Purchase of fixed assets | -117.20%-48.71M | 62.58%-36.76M | 58.69%-22.43M | 42.23%-98.24M | 9.06%-54.28M | 46.17%-170.07M | 72.83%-59.69M | -3.23%-315.92M | -528.02%-219.67M | 54.20%-306.05M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.37%-152K |
| Sale of subsidiaries | ---- | ---- | ---- | ---52K | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 4,570.71%765.06M | 110.43%16.38M | --16.38M | --7.78M | ---- | ---- | ---- | -90.62%26.48M | ---- | --282.31M |
| Cash on investment | ---- | ---- | ---- | 18.74%-4.12M | ---- | 77.02%-5.07M | ---- | 96.86%-22.08M | ---- | -2,920.48%-702.41M |
| Other items in the investment business | -76.04%27.33M | -69.77%13.04M | 3,276.06%114.08M | 197.17%43.12M | 94.21%-3.59M | -245.06%-44.38M | -391.35%-62M | -52.41%30.6M | 107.63%21.28M | 13,209.73%64.29M |
| Net cash from investment operations | 586.46%743.44M | 90.14%-2.89M | 375.35%108.3M | 86.97%-29.3M | 59.29%-39.33M | -15.98%-224.9M | 1.56%-96.62M | 65.27%-193.91M | -97.77%-98.15M | 24.69%-558.33M |
| Net cash before financing | 217.97%657.29M | 24.75%246.57M | 138.43%206.72M | 133.62%197.65M | 213.94%86.7M | 108.17%84.6M | 91.57%-76.09M | -181.58%-1.04B | -276.61%-903.03M | 369.28%1.27B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -81.40%151.45M | -49.84%960.27M | -7.05%814.36M | -31.41%1.91B | -46.51%876.09M | -40.24%2.79B | -31.84%1.64B | 83.18%4.67B | 55.41%2.4B | -41.18%2.55B |
| Refund | 29.66%-559.76M | 49.13%-1.03B | 14.84%-795.75M | 32.43%-2.02B | 40.24%-934.41M | 24.56%-2.99B | 11.04%-1.56B | -10.24%-3.96B | 4.08%-1.76B | 12.38%-3.6B |
| Issuing shares | ---- | ---- | ---- | --228.03M | ---- | ---- | ---- | ---- | ---- | 70,026.71%296.64M |
| Interest paid - financing | ---- | 41.32%-162.36M | ---- | -45.66%-276.68M | ---- | -34.39%-189.96M | ---- | 12.73%-141.35M | ---- | 23.23%-161.97M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 83.31%-16.02M | ---- | -265.44%-95.98M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 14.62%-11.47M | ---- | 46.50%-13.44M | ---- | -41.68%-25.11M | ---- | -128.58%-17.72M |
| Other items of the financing business | 27.56%-67.79M | ---- | -204.41%-93.57M | ---- | 66.92%-30.74M | ---4.29M | -59.74%-92.93M | ---- | 35.29%-58.18M | -333.58%-38.06M |
| Net cash from financing operations | -535.17%-476.1M | -34.77%-241.4M | 15.84%-74.96M | 57.76%-179.12M | -371.61%-89.06M | -183.45%-424.04M | -103.22%-18.89M | 147.07%508.14M | 255.87%586.7M | -2,949.82%-1.08B |
| Effect of rate | 729.04%6.2M | 55.47%-4.81M | 90.21%-985K | -991.16%-10.79M | -51.69%-10.06M | -44.85%1.21M | -13.10%-6.63M | -89.07%2.2M | -2,827.44%-5.86M | 343.06%20.1M |
| Net Cash | 37.52%181.19M | -72.09%5.17M | 5,675.92%131.76M | 105.46%18.53M | 97.51%-2.36M | 35.65%-339.44M | 69.97%-94.98M | -377.77%-527.45M | -334.47%-316.32M | -19.24%189.88M |
| Begining period cash | 0.30%122.81M | 6.74%122.44M | 6.74%122.44M | -74.67%114.71M | -74.67%114.71M | -53.70%452.93M | -53.70%452.93M | 27.33%978.18M | 14.53%978.18M | 41.90%768.2M |
| Cash at the end | 22.50%310.2M | 0.30%122.81M | 147.56%253.22M | 6.74%122.44M | -70.89%102.28M | -74.67%114.71M | -46.44%351.32M | -53.70%452.93M | -33.68%655.99M | 27.33%978.18M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | -6.42%122.81M | ---- | --131.23M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | -6.42%122.81M | ---- | --131.23M | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.